Depression Therapeutics Market Will Generate Record Revenue by 2029
Depression Therapeutics Market is expected to grow at a significant CAGR during the forecast period. The rise in the geriatric population and changes in people's lifestyles are two primary factors driving the market growth. The ageing population is anticipated to grow continuously, at a uniform rate in the next 10 years. For instance, according to the World Health Organization (WHO), the number of people aged 60 years or above was around 900 million in 2015 and it is estimated to reach nearly 2.0 billion in 2050, with most of the increase in the developing countries. In 2019, in Japan, people aged 65 years or above held 28% of the total country’s population (126 million) and followed by it, Italy held 23%. Depression is one of the major conditions amongst older people having a significant effect on their well-being and quality of life.
People are being made aware of depression through
public awareness campaigns. Although public awareness is growing, this ailment
is still underdiagnosed and undertreated. The patient is treated with a
combination of psychotherapy and antidepressants. Selective serotonin reuptake
inhibitors are predicted to lead the drug class segment during the forecast
period owing to the high level of effectiveness and general safety.
Additionally, North America depression therapeutics market is significantly
driven by significant antidepressant consumption in the US, branded
medications, and an active lifestyle. Moreover, Europe depression therapeutics
market is driven by the rising public knowledge about depression and improved
healthcare facilities and initiatives by various government and non-government
organisations.
To Request a Sample of our Report on Depression
Therapeutics Market: https://www.omrglobal.com/request-sample/depression-therapeutics-market
Market Coverage
·
The market number available for – 2022-2030
·
Base year- 2022
·
Forecast period- 2021-2030
·
Segment Covered
·
Regions Covered- Globally
Competitive Landscape: Pfizer, Inc., Eli Lilly Co., H. Lundbeck A/S, and
Otsuka Holdings Co., Ltd., among others.
Depression Therapeutics Market Report by Segment
By Drug Type
•
Antidepressants
•
Antipsychotics
•
Others
By Indication
•
Major Depressive Disorder (MDD)
•
Bipolar Disorder
•
Seasonal Affective Disorder (SAD)
•
Premenstrual Dysphoric Disorder (PMDD)
•
Others
By Distribution Channel
•
Hospital Pharmacies
•
Retail Pharmacies
•
Online Pharmacies
A
full Report of Depression Therapeutics Market is Available @ https://www.omrglobal.com/industry-reports/depression-therapeutics-market
Depression Therapeutics Market by Region
· United
States
· Canada
Europe
· UK
· Germany
· Spain
· France
· Italy
· Rest
of Europe
Asia-Pacific
· India
· China
· Japan
· South
Korea
· Rest
of APAC
Rest of the World
Reasons to buy from us –
1. We cover more than
15 major industries, further segmented into more than 90 sectors.
2. More than 120
countries are for analysis.
3. Over 100+ paid
data sources mined for investigation.
4. Our expert
research analysts answer all your questions before and after purchasing your
report.
For More Customized Data,
Request for Report Customization @ https://www.omrglobal.com/report-customization/depression-therapeutics-market
About Orion Market Research
Orion Market
Research (OMR) is a market research and consulting company known for its crisp
and concise reports. The company is equipped with an experienced team of
analysts and consultants. OMR offers quality syndicated research reports,
customized research reports, consulting and other research-based services. The
company also offer Digital Marketing services through its subsidiary OMR Digital and Software development and Consulting Services
through another subsidiary Encanto Technologies.
Media
Contact:
Company
Name: Orion Market Research
Contact
Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact
no: +91 7803040404
Comments
Post a Comment